A vast amount of work has studied the involvement of androgen receptors (ARs), estrogen receptor alpha (ESRα), and progesterone receptors (PRs) in the pathophysiology of ovarian cancer, with a particular interest in patient survival. Here, PGR is linked to ovarian cancer.